The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
Journavx is designed to eliminate the risks of addiction and overdose associated with medications like Vicodin and OxyContin.
The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain medicines. View on euronews ...
She had been in pain for the entire 90-minute flight. Her abdomen was so distended and tender that she felt as if it might ...
On Thursday, in a major step forward in pain management, the U.S. Food and Drug Administration has approved a new nonopioid ...
A recent survey revealed that many patients were worried about the physical effects of radiation, and more than one third ...
The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx (suzetrigine) ...